Equity - Additional Information (Details) - USD ($)		1 Months Ended			3 Months Ended	12 Months Ended
	Mar. 21, 2022	Aug. 31, 2022	Mar. 31, 2022	Oct. 31, 2021	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Feb. 28, 2023
Schedule of Equity Method Investments [Line Items]
Realized performance allocations and incentive fee related compensation, percentage				20.00%
Newly issued shares, fully vested in period (in shares)					86,317	850,110
Realized performance allocations and incentive fee related compensation					$ 4,800,000	$ 38,900,000
Stock repurchase program, authorized amount				$ 400,000,000
Common units repurchased						185,600,000	$ 161,800,000	$ 26,400,000
Remaining authorized amount						214,300,000
Purchase price paid for issuance of shares						194,500,000
Abingworth
Schedule of Equity Method Investments [Line Items]
Shares issued related to the acquisition of CBAM (in shares)		600,000
Purchase price paid for issuance of shares		$ 25,000,000				$ 25,000,000.0
Management Contracts
Schedule of Equity Method Investments [Line Items]
Newly issued common shares (in shares)	4,200,000		4,200,000
Purchase price paid for acquisition of management contracts related portfolio of assets	$ 194,500,000		$ 194,500,000
Scenario, Forecast
Schedule of Equity Method Investments [Line Items]
Stock repurchase program, authorized amount									$ 500,000,000